For citations:
Marinov DT, Perunov DV, Nefedova LN, Polyakov IS, Nasretdinov AF, Izmailov AA, Sultanbaev AV, Andrievskikh MI, Zukov RA, Obraz IL, Ovchinnikova EG, Grishin VA, Nikiforov AI, Rossokha EI, Galanov AS, Petkau VV, Mishina AV, Ponomarenko DM, Yukalchuk DY, Sannikova TA, Trefilova YV, Peganova EV, Kozlov VV, Sobolev AV, Modin NP, Gorokhov AE, Laktionov KK. Efficacy of alectinib in advanced ALK-positive non-small cell lung cancer: Results from the Russian multicenter KARL-005 study. Meditsinskiy sovet = Medical Council. 2026;(10):75-85. (In Russ.) https://doi.org/10.21518/ms2026-255
JATS XML
































